{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:54:33Z","timestamp":1787496873006,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,20]]},"DOI":"10.7759\/cureus.99724","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T21:20:03Z","timestamp":1766265603000},"source":"Crossref","is-referenced-by-count":1,"title":["BAP1 Loss as a Marker of Aggressive Clear Cell Renal Cell Carcinoma: Three Cases With Spinal Metastases"],"prefix":"10.7759","author":[{"given":"Nektarios","family":"Alevizopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Alexandris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaios","family":"Oreopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios N","family":"Kanellopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2022.07.022","article-title":"The expanding role of BAP1 in clear cell renal cell carcinoma","volume":"133","author":"Kapur P","year":"2023","unstructured":"Kapur P, Rajaram S, Brugarolas J. The expanding role of BAP1 in clear cell renal cell carcinoma. Hum Pathol. 2023, 133:22-31. 10.1016\/j.humpath.2022.07.022","journal-title":"Hum Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e3182a102d1","article-title":"PBRM1 and BAP1 as novel targets for renal cell carcinoma","volume":"19","author":"Brugarolas J","year":"2013","unstructured":"Brugarolas J. PBRM1 and BAP1 as novel targets for renal cell carcinoma. Cancer J. 2013, 19:324-32. 10.1097\/PPO.0b013e3182a102d1","journal-title":"Cancer J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nature22798","article-title":"BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation","volume":"546","author":"Bononi A","year":"2017","unstructured":"Bononi A, Giorgi C, Patergnani S, et al.. BAP1 regulates IP3R3-mediated Ca2+ flux to mitochondria suppressing cell transformation. Nature. 2017, 546:549-53. 10.1038\/nature22798","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2017.95","article-title":"Germline BAP1 mutations induce a Warburg effect","volume":"24","author":"Bononi A","year":"2017","unstructured":"Bononi A, Yang H, Giorgi C, et al.. Germline BAP1 mutations induce a Warburg effect. Cell Death Differ. 2017, 24:1694-704. 10.1038\/cdd.2017.95","journal-title":"Cell Death Differ"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang Y","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, et al.. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018, 20:1181-92. 10.1038\/s41556-018-0178-0","journal-title":"Nat Cell Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner T","year":"2011","unstructured":"Wiesner T, Obenauf AC, Murali R, et al.. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011, 43:1018-21. 10.1038\/ng.910","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-179","article-title":"BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs","volume":"10","author":"Carbone M","year":"2012","unstructured":"Carbone M, Ferris LK, Baumann F, et al.. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med. 2012, 10:179. 10.1186\/1479-5876-10-179","journal-title":"J Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone M","year":"2020","unstructured":"Carbone M, Harbour JW, Brugarolas J, et al.. Biological mechanisms and clinical significance of BAP1 mutations in human cancer. Cancer Discov. 2020, 10:1103-20. 10.1158\/2159-8290.CD-19-1220","journal-title":"Cancer Discov"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis S","year":"2012","unstructured":"Pe\u00f1a-Llopis S, Vega-Rub\u00edn-de-Celis S, Liao A, et al.. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet. 2012, 44:751-9. 10.1038\/ng.2323","journal-title":"Nat Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1246","article-title":"An empirical approach leveraging tumor grafts to dissect the tumor microenvironment in renal cell carcinoma identifies missing link to prognostic inflammatory factors","volume":"8","author":"Wang T","year":"2018","unstructured":"Wang T, Lu R, Kapur P, et al.. An empirical approach leveraging tumor grafts to dissect the tumor microenvironment in renal cell carcinoma identifies missing link to prognostic inflammatory factors. Cancer Discov. 2018, 8:1142-55. 10.1158\/2159-8290.CD-17-1246","journal-title":"Cancer Discov"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2017.0176","article-title":"Prognostic and clinicopathological significance of BAP1 protein expression in different types of cancer\u2014a meta-analysis","volume":"22","author":"Wang Z","year":"2018","unstructured":"Wang Z, Wang XY, Li J, Zhu WW. Prognostic and clinicopathological significance of BAP1 protein expression in different types of cancer\u2014a meta-analysis. Genet Test Mol Biomarkers. 2018, 22:115-26. 10.1089\/gtmb.2017.0176","journal-title":"Genet Test Mol Biomarkers"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425395-bap1-loss-as-a-marker-of-aggressive-clear-cell-renal-cell-carcinoma-three-cases-with-spinal-metastases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T21:20:04Z","timestamp":1766265604000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425395-bap1-loss-as-a-marker-of-aggressive-clear-cell-renal-cell-carcinoma-three-cases-with-spinal-metastases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.99724","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,20]]}}}